Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
about
Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infantsEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsLate (>7 days) postnatal corticosteroids for chronic lung disease in preterm infantsDelayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infantsModerately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsPostnatal steroid treatment and brain development.Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasiaGrowth retardation after dexamethasone administration: assessment by knemometry.Decreasing incidence of chronic lung disease despite the gradual reduction of postnatal dexamethasone use in very low birth weight infants.Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease.Postnatal glucocorticosteroid therapy for treatment and prevention of neonatal chronic lung disease.The effect of postnatal steroids on growth and development.Perinatal immunomodulation.Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Effects of antenatal and postnatal corticosteroids on the preterm lung.Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease.Cerebral haemodynamics in preterm infants after exposure to dexamethasoneMeasurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndromeEarly cortisol values and long-term outcomes in extremely low birth weight infants.Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network.Pathophysiology of neonatal lung injury.Bronchopulmonary dysplasia. Pharmacologic treatments and prediction of outcome.Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia.The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.Update on Postnatal Steroids.Hazards of systemic steroids for ventilator-dependent preterm infants: what would a parent want?Basic and translational research in neonatal pharmacology.Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials.Improving survival of patients with candidaemia: analysis of prognostic factors from a long-term, nationwide study in Iceland.The role of corticosteroids in respiratory diseases of children.Effects of dexamethasone on lung protein turnover.Dexamethasone in bronchopulmonary dysplasiaA catabolic state in dexamethasone treatment of bronchopulmonary dysplasia.The Pre-term Infant: Outcome 1985.Stopping the swinging pendulum of postnatal corticosteroid use.The effect of hydrocortisone on neurodevelopmental outcome in premature infants less than 29 weeks' gestation.The effect of dexamethasone upon platelets and neutrophils of preterm infants with chronic lung disease.Acute glucocorticoid treatment increases urinary biotin excretion and serum biotin.A randomized trial of inhaled versus intravenous steroids in ventilator-dependent preterm infants.
P2860
Q24194676-947EDC75-D565-4C15-B49E-DB69A53E780BQ24194710-EFB0120C-51C6-4A33-B310-1CA71B6B8F37Q24240398-33385DF2-1532-4ECD-9441-B5F7C16E6DD7Q24241502-99746DF4-FE72-4B22-88B1-B74457D2218BQ24250246-E377EB81-5FA4-49F1-B650-75A7869A9A59Q24250284-9781FAC4-D835-4613-8E6F-886574D851CBQ30907696-0CB74AB4-7454-477D-91BB-D8899D646B39Q33623353-10B90172-E2B6-4F75-893A-85955EE6CCC6Q33623976-1A36D0EC-48D4-4474-8CF7-89234E783723Q33631717-498A71AE-DF75-43DC-95F7-372633941BACQ33706562-99BCA730-C18A-4D82-9233-C77C96AA87E2Q34074665-D722A055-833E-4A14-8192-CCB9B945C84AQ34375033-398B9FBD-6ED8-4685-A60E-33E56C7A8595Q34975564-ABD39399-7234-4BB5-9C6F-E72074AB68EBQ35070866-E21105F2-869C-4D22-9C2F-2B5EEDE42999Q35286022-E1D196A6-5C0D-461C-8243-FF637BC0F167Q35287062-8822B868-426F-49F9-A75F-5978768E68C1Q35287363-55489732-34D2-484B-A752-674CB862A9FEQ36500274-49C0DB48-8CCE-40A3-B845-F706683386EDQ36650359-D56325CA-63AC-4482-8C4B-A0808D3095B5Q37613608-75DEE8B0-7B6F-4D62-AE0F-F8B4C2F7097CQ37726200-0D5F1F27-A793-47D7-889D-A77828C3BA13Q37726205-6164CC30-FC4F-4B67-A07C-6B901822840AQ38365794-34AECE42-D858-4725-AD78-D16AD3A1BD01Q38365940-FE2F0070-F62E-4E18-B9A7-3104DAE0B70EQ39326478-4BD8D73E-27C0-43AF-80A9-612B61D84C59Q39432755-96A355C3-C0B1-4D7E-8EEE-FCC5D7851BBEQ40312343-3933166A-C49D-4815-BDFC-B5B7033053EDQ40489148-8B07211F-B7B7-4247-BB4B-7F8FD3624C22Q40513183-B73CB064-3502-4119-A707-2D3F669C5D10Q41151318-7658D6CB-9791-4C3C-80C2-374859755859Q42207697-64DD5C71-DA00-4BFE-BC1A-71AB2F48244BQ42742785-60911808-360A-4A65-8DBA-CC7BA8D47F4CQ42965801-D472606A-C738-4930-8B83-327D24836D2EQ43158058-C4630760-60A2-41A1-8F8D-362D3B012EE9Q43160711-6BBFCBF9-428E-4FD3-A4D6-270841430D76Q43170005-E7730011-6C74-4C4C-A9E1-FB92FF044E22Q43599019-EC632918-FB53-4745-8621-416D3DADBAC3Q43879204-7F2BDE3D-619A-4759-877E-1B0CFBC2E53EQ43955933-FAFA82CF-1160-4C50-91BF-A11D60FB13DB
P2860
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
@en
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
@nl
type
label
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
@en
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
@nl
prefLabel
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
@en
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
@nl
P2093
P1433
P1476
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
@en
P2093
D E Johnson
M C Mammel
T R Thompson
P304
P356
10.1016/S0140-6736(83)92139-6
P407
P577
1983-06-01T00:00:00Z